Sarah Elizabeth Nash. Ms. Nash recently retired as Vice Chairman of J.P. Morgan Chase & Co.’s Investment Bank where she was responsible for the firm’s client relationships. Prior to these responsibilities, she was the Regional Executive and Co-Head of Investment Banking for North America at J.P. Morgan & Co.

Over her career at J.P. Morgan & Co., Sarah’s focus has been to build and broaden J.P. Morgan’s North American client franchise, beginning in the late 1970’s with Midwest client coverage. She developed and led J.P. Morgan’s Leveraged Finance business from 1985-1990. She initiated and led a business development team from 1990-1992, which then became the Investment Bank’s model for client coverage. Since 1992, Sarah has held a variety of senior management positions in Investment Banking. Over the years, her organizations have focused on growing the client franchise and as well as building a strong regional organization for J.P. Morgan. Her personal areas of expertise are strategic advisory, capital raising, and financial restructurings.

Since retiring from JPMorgan, Sarah has focused on investments in the biotechnology sector and serves on the board and head of Audit Committee of Merrimack Pharmaceuticals. Her other corporate board position is Knoll Inc. where she serves on the Compensation Committee.

Sarah’s philanthropic leadership responsibilities include her serving as a Trustee for New York-Presbyterian Hospital where Sarah serves on the Executive, Finance and Investment Committees and for Washington and Lee University. She is also a Trustee of The New-York Historical Society, The New York Restoration Project and serves on the Business Leadership Council of CUNY.

She grew up in Montreal, Canada and graduated from Vassar College in 1974. She began her career in marketing at IBM and then left in January, 1976 to join J.P. Morgan. She is a dual U.S.-Canadian citizen, is married and has two children.